Sanofi’s recent disclosure of safety problems with the world’s only approved vaccine against the dengue has complicated efforts to contain a growing global epidemic, public-health experts say.
from WSJ.com: US Business http://ift.tt/2CNReRS
via IFTTT
No comments:
Post a Comment